| Time |
Event |
| 7:45 a.m. - 8:00 a.m. |
PRO Program Welcome
Speaker: Najeeb Mohideen, MD, FASTRO, Northwest Community Hospital |
| 8:00 a.m. - 9:15 a.m. |
Session I – HPV Head and Neck Cancer: Maintaining Control While Minimizing Toxicity
Moderator: Arshin Sheybani, MD, John Stoddard Cancer Center
Speakers:
Management of p16+ Unknown Primary of the Head and Neck
Henry Soo-Min Park, MD, MPH, Yale University
Adjuvant Therapy After TORS for BOT Carcinoma
Sujith Baliga, MD, The Ohio State University
Management Options for Poor Performance Status Patient
Virginia Diavolitsis, MD, Riverside Radiation Oncology
Q&A |
| 9:30 a.m. - 10:45 a.m. |
Session II – Management of Brain and Spine Metastases
Moderators: Christine Chung, MD, Alta Bates Comprehensive Cancer Center
Virginia Diavolitsis, MD, Riverside Radiation Oncology
Speakers:
Management of Brain Metastases with Targeted Therapy
Lindsey Sloan, MD, PhD, University of Minnesota
Management of Large Volume or Multiple Brain Metastases
Tony Wang, MD, Columbia University Irving Medical Center
Management of Spine Metastases with SBRT
Kristin Redmond, MD, MPH, Johns Hopkins University School of Medicine
Q&A |
| 11:00 a.m. - 12:15 p.m. |
Session III – The Role of Radiation in Diffuse Large B-Cell Lymphoma
Moderators: Arshin Sheybani, MD, John Stoddard Cancer Center
Christopher Hayes Pope, MD, CARTI Cancer Center
Speakers:
Overview of High Grade and Diffuse Large B-Cell Lymphoma
Yolanda Tseng, MD, University of Washington
Management of Early Stage DLBCL
Bouthaina Dabaja, MD, FASTRO, The University of Texas MD Anderson Cancer Center
Role of Radiation Therapy in Relapsed or Refractory DLBCL
Christopher Kelsey, MD, FASTRO, Duke University Medical Center
The Role of Radiation Therapy in Patients Undergoing CAR T-Cell Therapy for Diffuse Large B-Cell Lymphoma (DLBCL)
Timothy Robinson, MD, PhD, Yale University
Q&A |
| 12:15 p.m. - 1:00 p.m. |
Break |
| 1:00 p.m. - 2:15 p.m. |
Session IV – Socioeconomic Session 1) Career Advancement for the Physician in Healthcare Organizations 2) Socioeconomic Update
Moderator: Najeeb Mohideen, MD, FASTRO, Northwest Community Hospital
Speakers:
Career Advancement for the Physician in Healthcare Organizations
Constantine Mantz, MD, FASTRO, GenesisCare
Socioeconomic Update
Anne Hubbard, MBA, American Society for Radiation Oncology
Q&A |
| 2:15 p.m. - 3:30 p.m. |
Session V – PRO: Gastrointestinal Cancer
Moderators: Najeeb Mohideen, MD, FASTRO, Northwest Community Hospital
Christine Chung, MD, Alta Bates Comprehensive Cancer Center
Speakers:
Liver SBRT
Aisling Barry, MD, Princess Margaret Cancer Centre, University Health Network, University of Toronto
Choosing Options in Rectal Cancer
Jessica Frakes, MD, H. Lee Moffitt Cancer Center and Research Institute
Update on GI Cancer
Randa Tao, MD, University of Utah
Q&A |
| 3:45 p.m. - 5:00 p.m. |
Session VI – PRO: Gynecologic Cancers: Practical Applications of Recent Data and Techniques
Moderator: Beant Gill, MD, Associates in Radiation Medicine
Speakers:
Endometrial Cancer: Stage IIIC Disease and Molecular Testing
Ann Klopp, MD, PhD, The University of Texas MD Anderson Cancer Center
Vulvar Cancer: Groin Management in the Era of Sentinel Node Biopsy
Sushil Beriwal, MD, MBA, FASTRO, Allegheny Health Network Cancer Institute
Cervical Cancer: Practical Aspects for Advanced Disease
Yasmin Hasan, MD, University of Chicago
Q&A |
| 5:00 p.m. - 6:15 p.m. |
Session VII – PRO: Lung: Navigating Treatment Decisions in Small Cell and Non-Small Cell Lung Cancer
Moderators: Christopher Hayes Pope, MD, CARTI Cancer Center
Virginia Diavolitsis, MD, Riverside Radiation Oncology
Speakers:
Radiation Therapy in Limited Stage Small Cell Lung Cancer
Tyler Wilhite, Md, UPMC Hillman Cancer Center
Challenging Non-Small Cell Lung Cancer Cases: Ultracentral Non-Small Cell Lung Cancer, Mediastinal Failures Post-SBRT, and Definitive Thoracic Re-Irradiation
Mattew Ning, MD, PhD, MD Anderson Cancer Center
Indications for Immunotherapy with Radiation and Role of Checkpoint Blockade in Management of Non-Small Cell Lung Cancer
Bradford Perez, MD, H. Lee Moffitt Cancer Center and Research Institute
Q&A |